Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Cash from Financing Activities (2022 - 2026)

Zentalis Pharmaceuticals has reported Cash from Financing Activities over the past 5 years, most recently at -$1.1 million for Q1 2026.

  • For Q1 2026, Cash from Financing Activities fell 694.18% year-over-year to -$1.1 million; the TTM value through Mar 2026 reached -$5.6 million, down 2028.97%, while the annual FY2025 figure was -$4.3 million, 4064.81% down from the prior year.
  • Cash from Financing Activities for Q1 2026 was -$1.1 million at Zentalis Pharmaceuticals, up from -$4.6 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $236.6 million in Q2 2023 and troughed at -$4.6 million in Q4 2025.
  • A 5-year average of $35.2 million and a median of $249000.0 in 2023 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: surged 2600.0% in 2025 and later crashed 694.18% in 2026.
  • Year by year, Cash from Financing Activities stood at $49.7 million in 2022, then crashed by 99.38% to $309000.0 in 2023, then crashed by 70.23% to $92000.0 in 2024, then plummeted by 5084.78% to -$4.6 million in 2025, then soared by 75.51% to -$1.1 million in 2026.
  • Business Quant data shows Cash from Financing Activities for ZNTL at -$1.1 million in Q1 2026, -$4.6 million in Q4 2025, and $115000.0 in Q3 2025.